A Trial for Patients With Advanced/Recurrent Cervical Cancer

Clinical trial NCT00190983 · COMPLETED

Trial details

NCT number: NCT00190983
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Uterine Neoplasms Genital Neoplasms, Female

Start date: 2005-02-01
Primary completion: 2007-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.